» Articles » PMID: 34663377

Modulation of Host Cell Signaling During Cytomegalovirus Latency and Reactivation

Overview
Journal Virol J
Publisher Biomed Central
Specialty Microbiology
Date 2021 Oct 19
PMID 34663377
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Human cytomegalovirus (HCMV) resides latently in cells of the myeloid compartment, including CD34 hematopoietic progenitor cells and circulating monocytes. Healthy hosts maintain the virus latently, and this infection is, for the most part, asymptomatic. However, given the proper external cues, HCMV reactivates from latency, at which point the virus disseminates, causing disease. The viral and cellular factors dictating the balance between these phases of infection are incompletely understood, though a large body of literature support a role for viral-mediated manipulation of host cell signaling.

Main Body: To establish and maintain latency, HCMV has evolved various means by which it usurps host cell factors to alter the cellular environment to its own advantage, including altering host cell signaling cascades. As early as virus entry into myeloid cells, HCMV usurps cellular signaling to change the cellular milieu, and this regulation includes upregulation, as well as downregulation, of different signaling cascades. Indeed, given proper reactivation cues, this signaling is again altered to allow for transactivation of viral lytic genes.

Conclusions: HCMV modulation of host cell signaling is not binary, and many of the cellular pathways altered are finely regulated, wherein the slightest modification imparts profound changes to the cellular milieu. It is also evident that viral-mediated cell signaling differs not only between these phases of infection, but also is myeloid cell type specific. Nonetheless, understanding the exact pathways and the means by which HCMV mediates them will undoubtedly provide novel targets for therapeutic intervention.

Citing Articles

Inhibition of MAPK signaling suppresses cytomegalovirus reactivation in CD34 Kasumi-3 cells.

Baruah V, Krishna B, Kelly M, Qi X, OConnor C bioRxiv. 2025; .

PMID: 39990446 PMC: 11844548. DOI: 10.1101/2025.02.13.638080.


CMV Infection Risk Factors and Viral Dynamics After Valganciclovir Prophylaxis: 10 Years of Experience in Lung Transplant Recipients.

Garcia-Masedo Fernandez S, Laporta R, Garcia Fadul C, Aguilar Perez M, Anel Pedroche J, Sanabrias Fernandez de Sevilla R Microorganisms. 2024; 12(11).

PMID: 39597748 PMC: 11596771. DOI: 10.3390/microorganisms12112360.


Delivery of US28 by incoming HCMV particles rapidly attenuates Akt activity to suppress HCMV lytic replication in monocytes.

Mahmud J, Geiler B, Biswas J, Miller M, Myers J, Matthews S Sci Signal. 2024; 17(851):eadn8727.

PMID: 39190708 PMC: 11460310. DOI: 10.1126/scisignal.adn8727.


Human cytomegalovirus and neonatal infection.

Lawrence S Curr Res Microb Sci. 2024; 7:100257.

PMID: 39070527 PMC: 11276932. DOI: 10.1016/j.crmicr.2024.100257.


Splenic Infarction in Acute Cytomegalovirus and Epstein-Barr Virus Concomitant Infection.

Kana T, Mehjabeen S, Kawamj A, Patel N, Shamim Z Cureus. 2023; 15(9):e46235.

PMID: 37908907 PMC: 10613588. DOI: 10.7759/cureus.46235.


References
1.
Krishna B, Wass A, OConnor C . Activator protein-1 transactivation of the major immediate early locus is a determinant of cytomegalovirus reactivation from latency. Proc Natl Acad Sci U S A. 2020; 117(34):20860-20867. PMC: 7456108. DOI: 10.1073/pnas.2009420117. View

2.
Miller W, Zagorski W, Brenneman J, Avery D, Miller J, OConnor C . US28 is a potent activator of phospholipase C during HCMV infection of clinically relevant target cells. PLoS One. 2012; 7(11):e50524. PMC: 3510093. DOI: 10.1371/journal.pone.0050524. View

3.
Vardouli L, Moustakas A, Stournaras C . LIM-kinase 2 and cofilin phosphorylation mediate actin cytoskeleton reorganization induced by transforming growth factor-beta. J Biol Chem. 2005; 280(12):11448-57. DOI: 10.1074/jbc.M402651200. View

4.
Chan G, Bivins-Smith E, Smith M, Yurochko A . NF-kappaB and phosphatidylinositol 3-kinase activity mediates the HCMV-induced atypical M1/M2 polarization of monocytes. Virus Res. 2009; 144(1-2):329-33. PMC: 2736317. DOI: 10.1016/j.virusres.2009.04.026. View

5.
Crawford L, Kim J, Collins-McMillen D, Lee B, Landais I, Held C . Human Cytomegalovirus Encodes a Novel FLT3 Receptor Ligand Necessary for Hematopoietic Cell Differentiation and Viral Reactivation. mBio. 2018; 9(2). PMC: 5915732. DOI: 10.1128/mBio.00682-18. View